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Abstract
Introduction: Bisphenol A and several of the most commonly used phthalates have been 
associated with adverse metabolic health effects such as obesity and diabetes. Therefore, 
we analyzed these man-made chemicals in first morning urine samples from 107 healthy 
normal-weight Danish children and adolescents.
Method: This was a cross-sectional study. Participants were recruited as part of the 
Copenhagen Puberty Study. The subjects were evaluated by an oral glucose tolerance 
test (OGTT), a dual-energy X-ray absorptiometry (DXA) scan, direct oxygen uptake 
measurement during cycle ergometry and fasting blood samples. First morning urine was 
collected and phthalate metabolites and BPA were measured by liquid chromatography-
tandem mass spectrometry (LC–MS/MS) with prior enzymatic deconjugation. Individual 
chemical concentrations were divided into tertiles and analyzed in relation to biological 
outcome.
Results: Children in the lowest tertile of urinary BPA had significantly higher peak 
insulin levels during OGTT (P = 0.01), lower insulin sensitivity index (P < 0.01), higher 
leptin (P = 0.03), triglyceride (P < 0.01) and total cholesterol levels (P = 0.04), lower aerobic 
fitness (P = 0.02) and a tendency toward higher fat mass index (P = 0.1) compared with 
children in the highest tertile for uBPA. No significant differences in anthropometrics, 
body composition or glucose metabolism were associated with any of the phthalate 
metabolites measured.
Conclusion: This pilot study on healthy normal-weight children suggests an inverse 
association between BPA and insulin resistance. Our findings contrast other cross-
sectional studies showing a positive association for BPA, which may be due to 
confounding or reverse causation because diet is an important source of both BPA 
exposure and obesity.
Introduction
Concerns have been raised that man-made chemicals such 
as phthalates and bisphenol A (BPA) may have endocrine 
properties in humans. These potential endocrine disruptive 
chemicals (EDCs) are widely used in modern societies, 
and the majority of the human population is exposed to 
several of these environmental chemicals daily (1).
BPA is an estrogenic high-volume chemical used as the 
base compound in the manufacturing of polycarbonated 
plastics and epoxy resins, which are used for a variety 
of plastic products and barrier coatings for the inner 
surfaces of food and beverage cans (2). Humans are 
primarily exposed to BPA through ingestion (3). Urinary 
10.1530/EC-17-0344
Key Words
 f endocrine-disrupting 
chemicals
 f children
 f OGTT
 f obesity
 f diabetes
Endocrine Connections
(2018) 7, 232–238
ID: 17-0344
7 1
This work is licensed under a Creative Commons 
Attribution 4.0 International License.https://doi.org/10.1530/EC-17-0344
http://www.endocrineconnections.org © 2018 The authors
Published by Bioscientifica Ltd
Downloaded from Bioscientifica.com at 02/27/2019 12:44:49PM
via University of Copenhagen and Kobenhavns Universitet
A Carlsson et al. BPA and HOMA in children 2337:1
BPA excretion has been positively associated with higher 
prevalence of diabetes (4) and obesity (5) in adults and 
obesity (6) in children.
Phthalates are used as softeners in PVC plastics. As 
phthalates are continuously emitted from PVC, humans 
can be exposed through ingestion, inhalation or by 
dermal contact (7). Serious adverse health effects have 
been associated with high phthalate exposure such as 
alteration in reproductive development and increased risks 
of insulin resistance and obesity in human adults (8, 9, 
10, 11, 12). Importantly, children may be at increased risk 
of exposure as phthalates are used in the manufacturing 
of many industrial products such as toys, building 
materials and food packaging (7). Despite increased 
regulations regarding the use of phthalates in children’s 
toys, detectable measures of phthalate metabolites are still 
being found in 97% of the childhood population (1). The 
exposure to phthalates has been associated with increased 
risk of obesity in childhood, but data are equivocal (6, 13, 
14). As for BPA, human data on effects of phthalates on 
insulin sensitivity are still lacking.
In the present study, urinary excretion of BPA and 
metabolites of the most commonly used phthalates in 107 
healthy normal-weight Danish children were associated 
to fasting lipids, leptin and adiponectin levels as well as 
to glucose and insulin levels during a two-h oral glucose 
tolerance test (OGTT).
Methods
Participants
Subjects were recruited as part of the Copenhagen Puberty 
Study (15, 16) from primary schools in the Copenhagen 
community. A total of 107 healthy Caucasian children 
(58 girls) aged 8.5–16.1 years volunteered. Characteristics 
of the children are specified in Table  1. All participants 
had total body fat and lean mass evaluated with a whole-
body dual-energy X-ray absorptiometry (DXA) scan 
using a CDR 1000/W densitometer (Hologic, Bedford, 
MA, USA) with software, version 6.2. Fat mass index was 
calculated as total fat mass divided by height squared. 
Aerobic fitness was evaluated by assessing maximal 
oxygen uptake (VO2max) during a cycle ergometry test 
using an electronically braked cycle ergometer (Ergomedic 
839: Monark, Varberg, Sweden). VO2max was measured 
directly using an online pulmonary gas analyzer system 
(Quark CPET; Cosmed, Rome, Italy). Data on OGTT, body 
composition as well as other aspects have previously been 
published (17, 18). The study was approved by the local 
ethics committee (reference no. KF 01 282214 and KF 11 
2006-2033). Consent has been obtained from each patient 
or subject after full explanation of the purpose and nature 
of all procedures used.
Blood sampling
Venous fasting blood samples were drawn after 12 h of 
fasting from the ante-cubital vein into standard vacuum 
tubes and centrifuged (3000 g at 10 min) within 30 min. 
Plasma was immediately stored at −20°C until analysis. A 
standard two-h OGTT with an oral glucose load of 1.75 g of 
glucose per kilogram bodyweight (maximum 75 g glucose) 
was performed for all subjects. Blood samples were drawn 
with 30-min intervals for determination of glucose and 
insulin levels. Insulin sensitivity index a.m. Matsuda was 
calculated. In addition, fasting leptin, adiponectin and 
lipid profiles (triglyceride, total cholesterol and high- and 
low-density lipoproteins) were determined as previously 
described (17).
Urine sample collection and chemical analysis
Each of the participants collected two consecutive first 
morning urine samples and one 24-h urine sample. All 
samples were collected in November 2007 and have 
Table 1 Basic characteristic of the 107 subjects included in 
the study.
Boys (n = 49) Girls (n = 58)
BMI (kg/m2) 18.07 (15.0–26.1) 18 (14.4–28.3)
Fat mass index 
(kg/m2)
3.2 (1.4–6.8) 3.6 (2.0–9.0)
Fasting glucose 
(mmol/L)
4.9 (3.9–5.9) 4.8 (3.2–5.4)
2-h glucose 
(mmol/L)
5. 1 (3–7.3) 5.1 (3.3–7.3)
Fasting insulin 
(pmol/L)
42 (10–102) 50 (11–168)
Peak insulin 
(mmol/L)
352 (112–1004) 407 (150–1329)
Triglycerides 
(mmol/L)
0.6 (0.4–1.7) 0.8 (0.4–2.0)
HDL (mmol/L) 1.5 (1.1–2.1) 1.5 (0.7–2.2)
LDL (mmol/L) 2.1 (0.5–3.2) 2.3 (0.8–3.8)
Total cholesterol 
(mmol/L)
3.6 (2.5–4.6) 3.7 (2.6–5.6)
Leptin (ng/mL) 3987 (884–37065) 6549 (1772–49495)
Adiponectin  
(μg/mL)
24532.5 (12100–57085) 27320 (9375–60190)
VO2max  
(mL/kg/min)
46.7 (30.3–63.2) 40.3 (25.1–49.3) 
Data are expressed as medians and range.
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previously been analyzed for the content of metabolites 
of the most common phthalate diesters; diethyl phthalate 
(DEP), di-n-butyl phthalate (DnBP), di-iso-butyl phthalate 
(DiBP), butylbenzyl phthalate BBzP, di-(2-ethyl-hexyl) 
phthalate (DEHP) and di-iso-nonyl phthalate (DiNP) and 
BPA as one out of nine environmental phenols measured 
by liquid chromatography-tandem mass spectrometry 
(LC–MS/MS) with prior enzymatic deconjugation (19, 20).
For the present study, first morning urine collected 
from the first of the two consecutive mornings was used.
Data analysis
The volume of urine was determined by converting the 
weight in grams of the collected urine into milliliters, as 
the urinary density is close to 1 g/mL (varies between 1.003 
and 1.035 g/mL). Urinary concentrations of phthalate 
metabolites (ng/mL) were measured and converted to 
absolute amount excreted (µg per first morning urine 
sample) by multiplying the urinary concentration in each 
sample with the urine volume (mL).
The metabolite concentration (ng/mL) of DiBP and 
DnBP were summed (∑MBP(i+n)) and in order to combine 
the phthalate metabolites with different molecular 
weight, the amount of each metabolite was converted 
into molar concentration, summed in groups and back-
converted into ng/mL by multiplying with the molecular 
weight of DEHP for the sums of four DEHP metabolites 
(∑DEHPm) and the molecular weight of DiNP for the 
sums of four DiNP metabolites (∑DiNPm). The molar sum 
of all measured phthalate metabolites (∑all phth.m) were 
not back-converted but expressed in µM.
Statistics
Urinary BPA, monoethyl phthalate (MEP), ∑MBP(i+n), 
monobenzyl phthalate (MBzP), ∑DEHPm, ∑DiNPm and 
∑all phth.m were log-transformed to assure a Gaussian 
distribution. Correlations between the summed phthalates 
and BPA levels were evaluated by Pearson Correlations.
The compounds were divided into tertiles allowing 
children with urinary excretion levels below the limit 
of detection (LOD) to be included. Differences in 
metabolic parameters between tertiles were evaluated by 
independent Student t-tests. Peak insulin levels, insulin 
sensitivity index, triglyceride levels, fat mass index and 
leptin levels were all log-transformed before analyses. 
Univariate ANOVAs (general linear models) were used for 
adjusted analyses with sex and pubertal stage (3 groups: 
pre-pubertal, breast/genital stage 2–3 and breast/genital 
stage 4–5) included as fixed variable and age as continuous 
variable. No significant interactions were found between 
sex and puberty in any of the reported models except for 
insulin sensitivity for which the results of the combined 
as well as the sex-specific analyses is shown. Potential 
confounders divided into BPA tertiles are shown in 
Table  2. All statistical analyses were done using the 
statistical software IBM SPSS, version 23.0.
Results
In total, 107 children were included in the analyses. 
One-hundred and four children (55 girls) completed a 
full 2-h glucose tolerance test, and aerobic fitness levels 
were available in 91 (48 girls). Basic characteristics of 
all children are shown in Table 1. None of the children 
had an abnormal glucose tolerance test. Eight children 
(5 girls) had urinary BPA below LOD (<0.12 ng/mL). Median 
and range of values of measured phthalate metabolites 
Table 2 Potential confounders divided into the BPA tertiles.
  
Low (n = 35)
Medium 
(n = 35)
 
High (n = 37)
Boys/Girls 
(n)
16/19 16/19 17/20
Age (years) 12.3 (8.7–15.4) 12.4 
(8.5–15.4)
12.3 (8.7–16.1)
Puberty 
(stage*)
8; 13; 14 7; 12; 16 12; 11; 14
BPA (ng/mL) 1.03 (<LOD–1.74) 2.55 
(1.38–4.11)
6.83 (3.82–17.32) 
*Breast/genital stage l; breast/genital stage 2–3; breast/genital stage 4–5.
Table 3 Levels of measured phthalate metabolites and BPA 
in the 107 children and adolescents included in the study.
n Median Range
MEP (ng/mL) 107 46.822542 3.6893–658.24
MBP (ng/mL) 107 190.09819 48.1209–713.1561
MBzP (ng/mL) 107 32.930963 3.0639–451.7129
∑DEHP (ng/mL) 107 167.5 50.5–771.5
∑DiNP (ng/mL) 107 31.1 6.6–673.3
∑corr Phth.m 
(µM) (nmol/mL)
107 2.054935 0.583–5.5409
∑alll Phth.m 
(µM) (nmol/mL)
107 1.627242 0.4334–5.0396
BPA (ng/mL) 107 2.76 <LOD–17.32
BP-3 (ng/mL) 107 1.484424 <LOD–136.4388
∑DCP (ng/mL) 107 0.93621 <LOD–23.3397
BPA, bisphenol A; MEP, monoethyl phthalate; MBP, monobutyl phthalate 
isomers; MBzP, monobenzyl phthalate; ∑DEHPm, sum of DEHP 
metabolites; ∑DiNPm, sum of DiNP metabolites; ∑all phth.m, sum of all 
phthalate metabolites (MEP, MiBP, MnBP, MBzP and metabolites of DEHP 
and DiNP).
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and BPA are shown in Table 3. All phthalate metabolites 
were positively correlated (r > 0.35; P < 0.01). BPA did not 
correlate with neither of the measured phthalate levels 
(r < 0.08; P > 0.43).
The lowest tertile of BPA had significantly higher 
peak insulin levels during OGTT (P = 0.01), lower insulin 
sensitivity index (P < 0.01), higher leptin (P = 0.03), 
triglyceride (P < 0.01) and total cholesterol levels 
(P = 0.04), lower aerobic fitness (P = 0.02) and a tendency 
toward higher fat mass index (P = 0.1) compared with the 
highest tertile for BPA (Fig. 1). No differences were found 
for adiponectin or lipoprotein levels between the BPA 
tertiles (all P > 0.2). Sex, age and pubertal development 
were equally distributed among tertiles (P > 0.4). Adjusted 
for sex, age and pubertal development, the highest BPA 
tertile was still significantly associated with lower peak 
insulin levels (28.7% (5.1–57.5), P = 0.02), higher insulin 
sensitivity index (22.1% (2.2–45.8), P = 0.03) and lower 
triglyceride levels (25.4% (5.5–48.9), P = 0.03) compared 
with the lowest BPA tertile (ANOVA). Due to the significant 
interaction between sex and pubertal development for 
insulin sensitivity index, sex-specific analyses were done. 
Although none of these analyses were significant, the 
parameter estimates were similar to the combined analysis 
(boys: 19.8% (−6.0 to 52.7), P = 0.14; girls: (26.5% (−2.6 to 
64.4), P = 0.08)). Additional adjustment for fat mass index 
did not change any of the results in the adjusted analyses 
(not shown). In adjusted analyses, no associations were 
found between BPA tertile and fat mass index or fitness 
levels, respectively (P > 0.16).
No significant differences in anthropometrics, body 
composition or glucose metabolism were found between 
tertiles of any of the phthalates measured (results 
not shown).
Figure 1
Bisphenol A (BPA) tertiles and the distribution of selected metabolic parameters within BPA tertiles.
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Discussion
In this clinical study of healthy normal-weight children, 
urinary BPA and phthalate metabolites were present in 
detectable levels in the majority of urine samples, but no 
association was found between current exposure to these 
chemicals and adverse effect on body composition or 
glucose metabolism. On the contrary, we found that the 
group of children with the highest urinary excretion of BPA 
had significantly lower glucose-stimulated peak insulin 
levels, better insulin sensitivity and lower triglyceride 
levels compared with the lowest exposed children. These 
results were independent of adiposity.
It is well documented that the general population 
and children in particular are exposed to manufactured 
chemicals such as phthalates and BPA (1, 21). The more 
important question is whether these exposures form a 
relevant health risk. The hypothesis that exposure to 
these chemicals during childhood predispose to obesity 
and metabolic disease is far from verified (5, 6, 22).
To shed more light on this issue, we aimed to evaluate 
the dynamics in glucose and insulin during a standard 
OGTT in relation to current BPA and phthalate exposure. 
We conducted a thorough body compositional and 
metabolic examination of 107 healthy children with 
concomitant determination of urinary excretion of BPA 
and phthalate levels in full morning urine.
Our present findings that the group of children with 
the highest BPA levels had better insulin sensitivity and 
lower triglyceride levels is contradictive to most previous 
studies in children (6, 23) and do not support that 
concurrent BPA exposure has adverse effects on glucose 
homeostasis. However, due to the cross-sectional design 
of the present study, the temporal cause–and-effect 
relationship could not be determined. The fact that higher 
BPA exposure should have a positive influence on glucose 
metabolism seems unlikely. Thus, reverse causality – that 
the children with the healthier and more active lifestyle 
were more exposed to BPA. This could hypothetically be 
through consumption of more food and drinks contained 
in BPA-coated packaging to compensate for the higher 
energy expenditure of the more active lifestyle.
Previous cross-sectional studies showing higher 
prevalence of obesity and diabetes in adults (4, 5, 24, 25) 
and obesity in children (23) with higher BPA exposure 
may also be due to reverse causality. Exposure to BPA 
is mainly through intake of food and drinks contained 
in BPA-coated packaging – and exposure to BPA will 
therefore on average be higher with higher caloric intake. 
Thus, high BPA excretion may simply be a biomarker for 
intake of excess calories in these studies. To avoid this 
confounding, detailed and reliable data on the dietary 
sources of BPA exposure, calorie intake and energy 
expenditure such as physical activity is of paramount 
importance and have not been taken into account in 
previous studies.
While human studies are conflicting regarding 
the potential harmful effect of BPA on metabolism, 
experimental rodent studies show a more consistent 
pattern of BPA having adverse effects on the metabolic 
system, though the exact effect of BPA is yet to be 
determined. In mice that received a high-fat diet, BPA 
exposure was associated with more severe insulin 
resistance (26) and increased body weight and fat mass 
(27). Another study found that BPA did not induce body 
weight or fat mass but was instead disrupting glucose 
homeostasis, and this in fact was aggravated by a high-fat 
diet (28). Altogether, this could suggest that high doses of 
BPA may have an independent role in promoting obesity 
and/or insulin resistance in mice – though it is important 
to note, that in these experimental studies, the rodents 
are treated with about a thousand times greater dose of 
BPA compared to the exposure of the children in our 
clinical study.
It has been suggested that the harmful effect of BPA 
may be limited to a window of susceptibility, proposing 
that prenatal exposure in children (29) or exposure 
during pregnancy (30) may have long-term deleterious 
consequences in mice. However, no human data are 
available to confirm these suggestions. We evaluated 
current exposure levels with current body composition 
and glucose metabolism in children and adolescents 
and found no evidence that current exposure of these 
metabolites has an harmful effect on body composition 
or glucose metabolism at the time of exposure in healthy 
children, though further investigation is needed to prove 
of any long-term effects.
The lack of solid human data to confirm the results 
from the experimental models still renders the question if 
BPA has adverse effects on body composition and glucose 
metabolism in humans unanswered. Prospective studies 
with repeated measurement of BPA and metabolic risk 
profiling are needed before firm conclusion can be made.
An association between phthalate exposure and 
obesity has been suggested, but controversy exists. One 
study based on NHANES data showed a positive association 
between urinary levels of some phthalates and waist 
circumference in men but not in women (10). A study 
on the Swedish population showed the same, though the 
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association was only seen in women but not in men (31). 
Similarly, no consistent pattern is evident when assessing 
associations between phthalates and diabetes or markers 
of glucose metabolism (8, 32, 33). These inconsistencies 
could be due the same abovementioned reasons – the 
existence of reverse causality and the lack of dietary 
source of phthalate exposure. In the present study, no 
associations were found between phthalate exposure and 
either adiposity or glucose metabolism.
The strength of this investigation is the unselected 
sample of 107 well-characterized children. The primary 
limitation of this study is its small size, and the cross-
sectional design, which cannot show the temporal 
pattern of exposure and disease. Furthermore, our study 
population consists of healthy and normal-weight 
children, and we may therefore not have been able 
to observe the associations presented in other studies 
including overweight and obese subjects. In addition, 
since these chemicals do not persist in vivo, a first morning 
urine sample will only be suggestive of exposure for the 
previous day and may not give an accurate measure of 
long-term exposure. A high intra-individual day-to-day 
variation in urinary BPA excretion exists (34), which may 
lead to risk of exposure misclassification.
Conclusion
In conclusion, our study on healthy, normal-weight 
children do not support that current exposure to 
phthalates and bisphenols is associated with adverse 
effects on insulin resistance or adiposity. Other cross-
sectional studies showing positive association between 
BPA and obesity might be confounded by lack of data 
on caloric intake and energy expenditure. However, 
studies on murine models continue to show adverse 
health effect. Therefore, further prospective studies 
with serial measurements of the chemicals of interest, 
detailed measures of nutrient intake and energy 
expenditure, as well as long-term follow-up are greatly 
warranted.
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